WCN26-4189 Desmopressin as a Promising Therapeutic Approach for the Polyuric Phenotype in Patients with LRBA Deficiency

Read full text Summarise with VIRAT
Authors: Kanako Nagaoka, Fumiaki Ando, Tamami Fujiki, Yu Hara, Hideki Yanagawa, Soichiro Suzuki, Hiroaki Kikuchi, Shintaro Mandai, Yutaro Mori, Takayasu Mori, Koichiro Susa, Eisei Sohara
+1 more Shinichi Uchida
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Lipopolysaccharide-responsive and beige-like anchor protein (LRBA) deficiency is a rare genetic disorder characterized by immune dysregulation. The immune checkpoint molecule cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) fails to perform proper membrane trafficking in the absence of LRBA. In addition to immune cells, LRBA localizes to intracellular vesicles in various epithelial cells; however, its physiological roles have not been accurately deciphered. Our previous studies demonstrated that the LRBA–protein kinase A (PKA) complex facilitates water transport by promoting vesicular trafficking of aquaporin-2 (AQP2) and AQP4 in renal collecting duct cells.

Fields of Study & Subjects

Ion Transport and Channel Regulation Electrolyte and hormonal disorders Immunodeficiency and Autoimmune Disorders

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
103825–103825
Publication date
25 March 2026
Language
EN